# Novo Nordisk aims to slash the time it takes to bring new drugs to market by up to two-thirds.

*biotech · news · 2026-05-22 · MarketScreener*

## Key points

- Novo Nordisk aims to cut new drug launch timelines by up to two-thirds using AI.
- AI is now deeply integrated in Novo Nordisk’s India operations, especially in Bengaluru.
- The Bengaluru centre plays a pivotal role in nearly all global drug launches, including the new oral obesity pill.
- Novo Nordisk has revised its hiring targets downward, focusing on AI-driven efficiency over headcount.

**Companies:** Novo Nordisk
**Countries:** Denmark, India, United States

[Read the full story on MarketScreener](https://www.marketscreener.com/news/novo-nordisk-uses-ai-to-fast-track-drug-launches-expand-india-role-ce7f5adfd189f42d)

---

Canonical: https://newsio.io/n/85efc068-ca32-46ee-a79e-134acd0a6b3b/novo-nordisk-aims-to-slash-the-time-it-takes-to-bring-new-drugs-to-market-by-up
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works